JPS61225115A - Double capsule and oral composition containing said capsule - Google Patents
Double capsule and oral composition containing said capsuleInfo
- Publication number
- JPS61225115A JPS61225115A JP6569685A JP6569685A JPS61225115A JP S61225115 A JPS61225115 A JP S61225115A JP 6569685 A JP6569685 A JP 6569685A JP 6569685 A JP6569685 A JP 6569685A JP S61225115 A JPS61225115 A JP S61225115A
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- water
- drug
- substance
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 58
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 43
- 229940079593 drug Drugs 0.000 claims abstract description 31
- 239000003814 drug Substances 0.000 claims abstract description 31
- 239000000126 substance Substances 0.000 claims abstract description 28
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 20
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 20
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 20
- 229940088594 vitamin Drugs 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 9
- 235000013343 vitamin Nutrition 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- 108010010803 Gelatin Proteins 0.000 claims abstract description 8
- 239000008273 gelatin Substances 0.000 claims abstract description 8
- 229920000159 gelatin Polymers 0.000 claims abstract description 8
- 235000019322 gelatine Nutrition 0.000 claims abstract description 8
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 7
- 241000411851 herbal medicine Species 0.000 claims description 6
- 239000011162 core material Substances 0.000 claims 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 14
- 239000004094 surface-active agent Substances 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 4
- 229910052751 metal Inorganic materials 0.000 abstract description 3
- 239000002184 metal Substances 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 3
- 239000011248 coating agent Substances 0.000 abstract description 2
- 238000000576 coating method Methods 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 150000002739 metals Chemical class 0.000 abstract description 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000003205 fragrance Substances 0.000 description 17
- -1 beeswax Chemical class 0.000 description 14
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 12
- 239000004299 sodium benzoate Substances 0.000 description 12
- 235000010234 sodium benzoate Nutrition 0.000 description 12
- 239000000606 toothpaste Substances 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 229940034610 toothpaste Drugs 0.000 description 10
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000012188 paraffin wax Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- 239000005639 Lauric acid Substances 0.000 description 5
- 235000021360 Myristic acid Nutrition 0.000 description 5
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 235000010418 carrageenan Nutrition 0.000 description 5
- 239000000679 carrageenan Substances 0.000 description 5
- 229920001525 carrageenan Polymers 0.000 description 5
- 229940113118 carrageenan Drugs 0.000 description 5
- 239000000551 dentifrice Substances 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 229940042585 tocopherol acetate Drugs 0.000 description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940067596 butylparaben Drugs 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 3
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 108700004121 sarkosyl Proteins 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 239000001177 diphosphate Substances 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- VJESJEJNMGVQLZ-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(=O)N(CCO)CCO VJESJEJNMGVQLZ-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000735234 Ligustrum Species 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000920652 Quercus lusitanica Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 101000870046 Sus scrofa Glutamate dehydrogenase 1, mitochondrial Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940071145 lauroyl sarcosinate Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- SKDZEPBJPGSFHS-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)N(CCO)CCO SKDZEPBJPGSFHS-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、系中で不安定な水溶性薬剤を2重カプセル内
に封入して安定化させたカプセル及び該カプセルを配合
した歯磨などの口腔用組成物に関するものである。Detailed Description of the Invention [Field of Industrial Application] The present invention provides a capsule in which a water-soluble drug that is unstable in a system is encapsulated in a double capsule to stabilize it, and a toothpaste containing the capsule. The present invention relates to an oral composition.
従来から各種ビタミン類、生薬及びその抽出物を配合し
、その薬効を訴求した歯磨が種々開発されている。とこ
ろが、これらの薬剤は、歯磨中に存在する界面活性剤、
香料、金属などによって影響を受けやすく、保存中に薬
効が低下してしまい、使用時に効果が十分発揮されない
という問題があった。すなわち、上記の系にこれらの薬
剤を長期間安定に配合しておくことが困難であるとされ
ているのである。特にビタミンCであるアスコルビン酸
を歯磨に配合すると、歯肉炎の予防、口臭除去効果がす
ぐれろといわれているが、上記の原因により酸化が促進
されて薬効が大幅に低下してしまうので、アスコルビン
酸を誘導体化する方法(特開昭59−27810号)、
銅クロロフィル類(特公昭47−10399号)やキレ
ート剤などの安定化剤を添加する方法、カプセル化(特
公昭50−25011号)する方法等により安定化する
方法が提案されている。しかしながら、アスコルビン酸
を安定な形の誘導体とすると、アスコルビン酸本来の効
果が低下してしまい、又各種安定化剤の添加では、歯磨
中での長期安定性を得るのが困難である。さらに、上記
カプセル化は、アスコルビン酸等の水溶性薬効剤固体粉
末を含む細粒をワックス様物質で被覆した細粒状カプセ
ルを用いるものであるが、これとて未だ十分な安定化は
得られていない。BACKGROUND ART Various toothpastes containing various vitamins, herbal medicines, and their extracts have been developed to appeal to their medicinal effects. However, these drugs do not contain surfactants, which are present in toothpaste.
The problem is that it is easily affected by fragrances, metals, etc., and its medicinal efficacy decreases during storage, making it less effective when used. That is, it is considered difficult to stably incorporate these drugs into the above-mentioned system for a long period of time. In particular, it is said that ascorbic acid, a form of vitamin C, is effective in preventing gingivitis and eliminating bad breath when added to toothpaste. Method for derivatizing acids (JP-A-59-27810),
Stabilization methods have been proposed, such as adding stabilizers such as copper chlorophylls (Japanese Patent Publication No. 47-10399) and chelating agents, and encapsulation (Japanese Patent Publication No. 50-25011). However, when ascorbic acid is made into a stable derivative, the original effects of ascorbic acid are reduced, and it is difficult to obtain long-term stability in tooth brushing by adding various stabilizers. Furthermore, the above-mentioned encapsulation uses fine granular capsules in which fine particles containing a solid powder of a water-soluble medicinal agent such as ascorbic acid are coated with a wax-like substance, but sufficient stabilization has not been achieved yet. do not have.
従って、本発明は、共存物質により影響を受は失効しや
すい水溶性薬剤を、長期間安定に保持できるカプセル及
び該カプセルを配合した口腔用組成物を提供することを
目的とする。Therefore, an object of the present invention is to provide a capsule capable of stably retaining a water-soluble drug that is susceptible to expiration due to coexisting substances for a long period of time, and an oral composition containing the capsule.
本発明は、口腔組成物中の共存物質により影響を受けや
すい水溶性薬剤を溶液状態とし、これを特定の層構成を
有する2重カプセル内に封入したものを用いると、保存
安定性が大幅に向上すること、使用時にカプセルから速
やかに放出されてすぐれた薬効を発揮すること及び特に
アスコルビン酸はスティン除去効果にすぐれることを見
出し、本発明をなすに至った。According to the present invention, storage stability can be greatly improved by forming a water-soluble drug that is easily affected by coexisting substances in an oral composition into a solution state and encapsulating this in a double capsule having a specific layer structure. The present inventors have discovered that ascorbic acid has an excellent stain-removing effect, that it is quickly released from the capsule during use and exhibits excellent medicinal efficacy, and that ascorbic acid in particular has an excellent stain-removing effect.
すなわち、本発明は、ビタミン、生薬及びその抽出物の
群から選ばれる水溶性薬剤を芯剤とし、これを親油性物
質で被覆し、さらにこれらを親水性物質で被覆した構造
の2重カプセル及び該カプセルを含有することを特徴と
する口腔用組成物を提供する。That is, the present invention provides a double capsule with a structure in which a water-soluble drug selected from the group of vitamins, herbal medicines and extracts thereof is used as a core agent, this is coated with a lipophilic substance, and these are further coated with a hydrophilic substance. An oral composition containing the capsule is provided.
本発明で用いる2重カプセルの粒径は、特に限定されな
いが、カプセルの破壊しやすさから通常10〜5000
μm1好ましくは100−1000μmである。そして
、カプセルの芯となる水溶性薬剤としては、ビタミン、
生薬及びその抽出物から選ばれる少なくとも1種の水溶
性薬剤が用いられる。具体的には、各種ビタミンB、ビ
タミンC(アスコルビン酸)、桔梗、甘草、黄柏、シャ
コラ等の生薬成分が例示される。これらのうち、アスコ
ルビン酸を用いるとスティン除去が効果的に行なわれる
ので好ましい。これらの水溶性薬剤は粉末ではなくて、
溶液の形で用いられる。例えば5〜90重量%(以下、
%と略称する)、好ましくは10〜50%濃度で用いら
れる。この際溶媒としては、水又はグリセリンやソルビ
ットなどの多価アルコール類が用いられる。水を用いる
場合には、溶存酸素による酸化を防止するために酸素を
除いたものを用いるのが望ましい。又、多価アルコール
を用いる場合において、水溶性薬剤が溶解しない場合に
は、分散させた形態で使用するのがよい。本発明におい
ては、このように水溶性薬剤を粉体のままではなくて、
溶液の形態として用いているので、カプセルが破壊した
際に速やかに薬剤が系中に放出され、歯みがき等の短時
間の間に口腔内に作用してすぐれた効果を発揮するので
ある。The particle size of the double capsule used in the present invention is not particularly limited, but it is usually 10 to 5,000 from the viewpoint of ease of breaking the capsule.
μm1 is preferably 100-1000 μm. The water-soluble drugs that form the core of the capsule include vitamins,
At least one water-soluble drug selected from crude drugs and extracts thereof is used. Specifically, various herbal medicine ingredients such as vitamin B, vitamin C (ascorbic acid), bellflower, licorice, yellow oak, and shakola are exemplified. Among these, it is preferable to use ascorbic acid because it effectively removes stain. These water-soluble drugs are not powders,
Used in solution form. For example, 5 to 90% by weight (hereinafter,
%), preferably at a concentration of 10 to 50%. At this time, water or polyhydric alcohols such as glycerin and sorbitol are used as the solvent. When using water, it is desirable to use water from which oxygen has been removed to prevent oxidation due to dissolved oxygen. Further, when using a polyhydric alcohol, if the water-soluble drug is not dissolved, it is preferable to use it in a dispersed form. In the present invention, the water-soluble drug is not kept as a powder, but
Since it is used in the form of a solution, when the capsule is ruptured, the drug is quickly released into the system and acts on the oral cavity during a short period of time, such as when brushing teeth, and exerts excellent effects.
カプセルの内層剤、すなわち上記芯剤を被覆するのに用
いる物質としては、親油性物質が用いられ、融点が50
℃以上のワックス様物質、具体的にはパラフィンワック
ス、マイクロクリスクリンワックス等の炭化水素類、ミ
ツロウ、カルナウノくロウ、イボタロウ等のろう類、ス
テアリン酸、ノくルミチン酸、レヘニン酸、セロチン酸
等の高級脂肪酸、ステアリルアルコール、フエリルアル
コール等の高級アルコール、ポリエチレン、塩化ビニル
、ポリスチレン等の熱可塑性物質が例示される。The inner layer agent of the capsule, that is, the substance used to coat the core agent, is a lipophilic substance with a melting point of 50.
Wax-like substances above ℃, specifically hydrocarbons such as paraffin wax and microcrystalline wax, waxes such as beeswax, carnano wax, and privet wax, stearic acid, noclumitic acid, lehenic acid, cerotic acid, etc. Examples include higher fatty acids, higher alcohols such as stearyl alcohol and ferryl alcohol, and thermoplastic substances such as polyethylene, vinyl chloride, and polystyrene.
又、カプセルの外層剤、すなわち、内層剤の外側に被覆
するための物質は、親水性物質であり、具体的にはゼラ
チン、カルボキシメチルセルロースナトリウム、アラビ
アゴム等が例示される。本発明では、特に内層に親油性
物質、外層に親水性物質を用いることを特徴とするもの
であり、これにより、芯剤の薬剤は、親油性膜によって
界面活性剤から保護され父親水性膜によって油性成分で
ある香料から保護されるのである。従って、親油性成分
、親水性成分とを種々任意に組合せることができるが、
内層剤としてパラフィン、外層剤としてゼラチンを用い
ると、酸素の透過も抑制できるので好ましい。この場合
、カプセルを形成した後、グルタルアルデヒド、ホルマ
リン等のアルデヒド類、明ばん等の無機物により、外層
のタンパク質を硬化させると一層効果的である。Further, the outer layer agent of the capsule, that is, the substance for coating the outer side of the inner layer agent, is a hydrophilic substance, and specific examples thereof include gelatin, sodium carboxymethyl cellulose, gum arabic, and the like. The present invention is particularly characterized by using a lipophilic substance in the inner layer and a hydrophilic substance in the outer layer, whereby the drug in the core agent is protected from the surfactant by the lipophilic film and protected by the hydrophilic film. This protects it from fragrances, which are oil-based ingredients. Therefore, various combinations of lipophilic components and hydrophilic components can be made as desired;
It is preferable to use paraffin as the inner layer agent and gelatin as the outer layer agent because oxygen permeation can also be suppressed. In this case, after forming the capsule, it is more effective to harden the protein in the outer layer with an aldehyde such as glutaraldehyde or formalin, or an inorganic substance such as alum.
本発明の2重カプセルは例えば次に示す方法により容易
に製造できるものである。先づアスコルビン酸などの水
溶性薬剤含有溶液を融解分散冷却法によって親油性膜で
覆い、次に相分離により親水性膜を親油性膜上に析出さ
せて製造する。次いで所望により、カプセルを強固なも
のとするために、前記のタンパク質硬化剤を加えること
ができる。The double capsule of the present invention can be easily manufactured, for example, by the method shown below. It is produced by first covering a solution containing a water-soluble drug such as ascorbic acid with a lipophilic film by a melt-dispersion cooling method, and then depositing a hydrophilic film on the lipophilic film by phase separation. If desired, protein hardening agents as described above can then be added to toughen the capsules.
本発明の2重カプセルは本質的に」1記の構成を有する
ものであり、芯剤の量、内層、外層の厚さ等を任意とず
ろことができるが、芯剤である水溶性薬剤含有溶液10
〜90%、内層5〜40%、外層5〜50%、より好ま
しくは、それぞれ40〜60%、15〜20%、25〜
40%とするのがよい。The double capsule of the present invention essentially has the structure described in 1. The amount of the core agent, the thickness of the inner layer, the outer layer, etc. can be adjusted arbitrarily, but the double capsule containing the water-soluble drug as the core agent solution 10
~90%, inner layer 5~40%, outer layer 5~50%, more preferably 40~60%, 15~20%, 25~
A good value is 40%.
本発明においては、上記の2重カプセルを、各種歯磨、
洗口剤、歯肉マツサージ剤、チューインガム等に配合す
ることができる。この際、上記2重カプセルの口腔組成
物中での配合量は特に限定されないが好ましくは1〜5
0%配合する。そして、本発明の口腔組成物のその他の
成分としては、その種類等に応じて、通常使される成分
を配合することができる。例えば、歯磨組成物の場合に
は、次の成分を配合することができる。In the present invention, the above-mentioned double capsules can be used in various toothpastes,
It can be blended into mouthwashes, gum surgers, chewing gums, etc. At this time, the amount of the above-mentioned double capsule in the oral composition is not particularly limited, but is preferably 1 to 5.
Add 0%. As other components of the oral composition of the present invention, commonly used components can be blended depending on the type thereof. For example, in the case of a dentifrice composition, the following components can be blended.
研磨剤
酸化アルミニウム化合物、第2リン酸カルシウム・2水
和物及び無水物、無水ケイ酸、アルミノシリケート、炭
酸カルシウム、ピロリン酸カルシウム、ケイ酸アルミニ
ウム、不活性メタリン酸ナトリウム、第3リン酸マグネ
シウム、炭酸マグネシウム、硫酸カルシウム、合成樹脂
等の1種又は2種以上を通常全体の20〜90%、特に
練歯磨の場合には20〜60%配合できる。Abrasive aluminum oxide compound, dibasic calcium phosphate dihydrate and anhydride, silicic anhydride, aluminosilicate, calcium carbonate, calcium pyrophosphate, aluminum silicate, inert sodium metaphosphate, tribasic magnesium phosphate, magnesium carbonate, One or more of calcium sulfate, synthetic resin, etc. can be blended in an amount of usually 20 to 90% of the total amount, particularly 20 to 60% in the case of toothpaste.
粘結剤
カラゲナン、カルボキシメチルセルロースナトリウム、
アルギン酸ナトリウム、ガム頚、ポリビニルアルコール
、ビーガム等の1種又は2種以」二を通常、0.3〜5
%配合する。Binder carrageenan, carboxymethyl cellulose sodium,
One or more of sodium alginate, gum neck, polyvinyl alcohol, vegum etc. is usually 0.3 to 5
% blend.
粘稠剤
ソルビット、グリセリン、プロピレングリコール、1.
3−ブチレングリコール、ポリエチレングリコール、キ
シリット、マルナット、ラフチット等の1種又は2種以
上を、通常10〜70%配合する。Thickener sorbitol, glycerin, propylene glycol, 1.
One or more of 3-butylene glycol, polyethylene glycol, xylit, marnat, and lafutite are usually blended in an amount of 10 to 70%.
界面活性剤
ソジウムラウリルサルフェート、ラウロイルザルコシネ
ート、α−オレフィンスルホネート、タウレート、ラウ
リルモノグリセライドザルフェート、ラウリルモノグリ
セライドスルホネート、石げん等のアニオン活性剤、ラ
ウリン酸ジエクノールアミド、ステアリルモノグリセラ
イド、ショ糖脂肪酸エステル、ラクトース脂肪酸エステ
ル、ラクチトール脂肪酸エステル、マルチトール脂肪酸
エステル、ポリオキシエチレンソルビクンモノステアレ
ート等のノニオン活性剤、ベタイン型、アミノ酸型等の
両性活性剤などの1種または2種以上の界面活性剤を通
常0,5〜7%配合する。Surfactants Sodium lauryl sulfate, lauroyl sarcosinate, α-olefin sulfonate, taurate, lauryl monoglyceride sulfate, lauryl monoglyceride sulfonate, anionic active agents such as stone, lauric acid diechnolamide, stearyl monoglyceride, sucrose fatty acid ester , lactose fatty acid ester, lactitol fatty acid ester, maltitol fatty acid ester, nonionic surfactants such as polyoxyethylene sorbicun monostearate, and one or more surfactants such as amphoteric surfactants such as betaine type and amino acid type. is usually blended in an amount of 0.5 to 7%.
その他
サッカリンナトリウム、ステビオサイド、ネオヘスベリ
ジンジヒドロカルコン、タウマチン、クリチルリチン、
ペリラルチンなどの甘味剤、パラベンなどの防腐剤、メ
ントールやカルボンなどのテルペン系化合物等の各種香
料、ゼラチン、ペプトンなどを配合できる。さらに、デ
キストラナーゼ、アミラーゼ、プロテアーゼ、ムタナー
ゼ、リゾチーム、リテックエンザイム等の酵素、ソジウ
ムモノフルオロホスフェートなどのアルカリ金属モノフ
ルオロホスフェート、フッ化ナトリウム、フッ化第1錫
等のフッ化物、第1錫化合物、クロルヘキシジン塩類、
イプシロンアミノカプロン酸、トラネキサム酸、アルミ
ニウムクロルヒドロキシルアラントイン、ジヒドロコレ
ステロール、グリチルリチン塩類、塩化ナトリウム、水
溶性無機リン酸化合物等の薬剤を1種又は2種以上配合
することができる。Others include saccharin sodium, stevioside, neohesveridine dihydrochalcone, thaumatin, clityrrhizin,
Sweeteners such as perilartine, preservatives such as parabens, various fragrances such as terpene compounds such as menthol and carvone, gelatin, peptone, etc. can be added. Furthermore, enzymes such as dextranase, amylase, protease, mutanase, lysozyme, and Lytec enzyme, alkali metal monofluorophosphates such as sodium monofluorophosphate, fluorides such as sodium fluoride, and stannous fluoride; compounds, chlorhexidine salts,
One or more drugs such as epsilon aminocaproic acid, tranexamic acid, aluminum chlorohydroxylalantoin, dihydrocholesterol, glycyrrhizin salts, sodium chloride, and water-soluble inorganic phosphoric acid compounds can be blended.
」1記の成分を適量の水と練合し歯磨組成物を製造する
が、製造中又は製造後に上記2重カプセルを添加するこ
とができる。なお、このようにして得られた練歯磨組成
物は、アルミニウムチューブ、アルミニウム箔の両面を
プラスチック等でラミ不一トシたラミネートチューブ、
プラスチックチューブ、或いはボトル状容器、エアソー
ル容器等の所定の容器内に収容されて使用に供される。A dentifrice composition is produced by kneading the ingredients in item 1 with an appropriate amount of water, and the above-mentioned double capsule can be added during or after production. In addition, the toothpaste composition obtained in this way can be made into an aluminum tube, a laminate tube in which both sides of aluminum foil are laminated unevenly with plastic, etc.
It is stored in a predetermined container such as a plastic tube, a bottle-shaped container, an air-sol container, and the like for use.
また、他の口腔用組成物の場合も通常用いられる基材を
使用し、常法に従って製造することができる。Other oral compositions can also be produced using commonly used base materials and according to conventional methods.
本発明によれば、ビタミン順、生薬及びその抽出物が親
油性物質及び親水性物質によって彼覆されて保護されて
いるので、系中に存在する界面活性剤、油分である香料
成分及び微量の重金属によって変質することも又酸化を
促進されることもなく、口腔組成物中で長期間安定に保
持される。これに加えて、本発明の2重カプセルは、使
用に際して容易に破壊して内容物である上記薬剤を系中
に放出するが、この際上記薬剤は溶液の形態にあるので
、速やかに口腔内に作用することができる。According to the present invention, vitamins, herbal medicines, and their extracts are covered and protected by lipophilic substances and hydrophilic substances, so that surfactants, oily fragrance ingredients, and trace amounts of fragrance ingredients present in the system can be protected. It is neither altered by heavy metals nor promoted by oxidation, and is stably retained in oral compositions for long periods of time. In addition, the double capsule of the present invention is easily destroyed during use and releases the above-mentioned drug content into the system, but at this time, since the above-mentioned drug is in the form of a solution, it can quickly enter the oral cavity. can act on
従って、歯磨操作の短い時間であっても、薬剤が本来有
する薬効を効率よく発揮できるのである。Therefore, even when brushing teeth for a short period of time, the inherent medicinal effects of the drug can be efficiently exerted.
さらに上記の効果に加えて、水溶性薬剤がアスコルビン
酸の場合には、スティン(歯の周囲に付着する着色した
ペリクル、プラーク及び歯石等の総称)を有効に除去で
きることが見出された。すなわち、従来、スティン除去
に効果があるとされ □ている芳香族アルコール
は安全性面で問題があり、又、金属キレート剤は歯の構
成成分であるカルシウムをもキレートしてしまい、歯の
脱灰のおそれがあったが、本発明のアスコルビン酸含有
2重カプセルによれば、極めて安全である上にすぐれた
効果が得られるのである。Furthermore, in addition to the above-mentioned effects, it has been found that when the water-soluble drug is ascorbic acid, stain (a general term for colored pellicle, plaque, tartar, etc. that adheres to the periphery of teeth) can be effectively removed. In other words, aromatic alcohols, which have traditionally been thought to be effective in removing stains, have safety issues, and metal chelating agents also chelate calcium, a component of teeth, which can lead to tooth loss. Although there was a risk of ash, the ascorbic acid-containing double capsule of the present invention is extremely safe and provides excellent effects.
次に実施例により本発明を説明するが、本発明はこれら
に限定されるものではない。Next, the present invention will be explained with reference to Examples, but the present invention is not limited thereto.
実施例1
アスコルビン酸水溶性を封入した2重カプセルを歯磨組
成物に配合して、アスコルビン酸の安定性を調べた。2
重カプセルの製造方法及び歯磨組成を次に示す。Example 1 A double capsule containing water-soluble ascorbic acid was blended into a dentifrice composition, and the stability of ascorbic acid was investigated. 2
The method for producing heavy capsules and the toothpaste composition are shown below.
02重カプセルの製造方法
アスコルビン酸溶液(a度40%)を、融解したパラフ
ィンに投入した後、攪はんしてW/○エマルジョンをつ
くった。この際、アスコルビン酸溶液の液滴径を300
〜1000μ、系の温度をパラフィンの融点より1〜5
℃高い温度とした。このW / Oエマルジョンを適度
に攪拌しながらこの系と同温の水に除々に加えてW10
/Wエマルジョンを作った。その後、急冷してパラフィ
ンを固化させ、カプセルと水とを分離した(単膜カプセ
ル完成)。02 Method for producing double capsules Ascorbic acid solution (a degree 40%) was poured into melted paraffin and stirred to prepare a W/○ emulsion. At this time, the droplet diameter of the ascorbic acid solution was
~1000μ, the temperature of the system is 1~5 below the melting point of paraffin.
℃ higher temperature. Gradually add this W/O emulsion to water at the same temperature as this system with moderate stirring to make W10.
/I made a double emulsion. Thereafter, the paraffin was rapidly cooled to solidify, and the capsule and water were separated (single membrane capsule completed).
次に、このカプセルをゼラチン、アラビアゴム水溶液に
加えて分散させた後、10%酢酸を加えr+Hを除々に
下げてパラフィンのまわりにゼラチンを析出させた。最
後にタンパク質硬化剤であるクルクルアルデヒドを加え
てセラチン膜を硬化させ、カプセルを分離した。Next, this capsule was added to an aqueous solution of gelatin and gum arabic to disperse it, and then 10% acetic acid was added and r+H was gradually lowered to precipitate gelatin around the paraffin. Finally, curcuraldehyde, a protein hardening agent, was added to harden the seratin membrane, and the capsules were separated.
このようにして得られた2重カプセルは、芯剤:アスコ
ルビン酸20%及び水30.0%、内層:パラフィン2
0%、外層:ゼラチン30%及び少量の色素の構成であ
った。The double capsule thus obtained had a core of 20% ascorbic acid and 30.0% water, an inner layer of paraffin 2
0%, outer layer: 30% gelatin and a small amount of pigment.
0歯磨組成
炭酸カルシウム 42.0%サッカリン
0.1%ソルビトール
22.0%香 料
1,0 %パラオキシ安息香酸エチル 0.
01%ラウリル硫酸ナトリウム 1.3%カプセ
ル 2.0%水
30.5 %尚、仕較例
として、カプセル化物の代りにアスコルビン酸0.4%
をそのまま添加した歯磨についても安定性を調べた。結
果をまとめて次に示す。尚、安定性はインドフェノール
滴定法により求めた。0 Toothpaste composition Calcium carbonate 42.0% Saccharin
0.1% sorbitol
22.0% fragrance
1.0% ethyl paraoxybenzoate 0.
01% Sodium Lauryl Sulfate 1.3% Capsule 2.0% Water
30.5% As a comparison example, ascorbic acid 0.4% was used instead of the encapsulated product.
We also investigated the stability of toothpaste containing the same ingredients. The results are summarized below. The stability was determined by indophenol titration.
アスコルビン酸の安定性
本発明品 1ヒ較例
2日後 100%残存 ずべて失活7日後 〃
14日後 ツノ
21日後 98%
28日後 94%
実施例2
研磨剤を含有しない歯磨組成物に実施例1で用いたカプ
セルを加え、スティンの除去効果を調べた。尚、仕較の
ためにカプセルを添加しないものについても試験を行な
った。歯磨組成及び結果を次に示す。Stability of ascorbic acid Inventive product 1 Comparative example 2 days later 100% remaining Completely deactivated 7 days later 〃 14 days later Horns 21 days later 98% 28 days later 94% Example 2 Example 1 was applied to a dentifrice composition that did not contain an abrasive. The capsules used in the above were added to examine the stain removal effect. For comparison, a test was also conducted with no capsules added. The toothpaste composition and results are shown below.
0歯磨組成
カルボポール 1.9%
85%グリセリン 20.5
ホウ酸Na ]・7炭酸ソータ
0.7
ザツカリンNa 0.2ラウリル
硫酸Na 1.5安息香酸Na
0.3香 料
0.5カプセル 1.5
水 7120試
験方法
試験開始時、およびザンプル交換時にスケーリングを行
ない、スティン付着率Oの状態とした後アスコルビン酸
配合製剤、アスコルビン酸を含まないブランク製剤で1
週間ずつ計2i1!I間歯をみがいた。各サンプル使用
後にスティン(プラーク)付着率をみた。0 Toothpaste composition Carbopol 1.9% 85% Glycerin 20.5 Sodium borate ]・7 Carbonate Sorta
0.7 Sodium zatukarin 0.2 Sodium lauryl sulfate 1.5 Sodium benzoate
0.3 fragrance
0.5 Capsules 1.5 Water 7120 Test Method Scaling was performed at the start of the test and at the time of sample replacement to obtain a stain adhesion rate of O.
A total of 2i1 each week! I brushed my teeth. After each sample was used, the stain (plaque) adhesion rate was observed.
0結 果
歯の裏側のスティン付着率は
本発明品 18.4
肚較例 23.O
であった(n=5)。すなわち、本発明品によれば、研
磨剤がなくともすぐれたスティン除去効果が発揮される
ことがわかる。尚、別の実験により、アスコルビン酸以
外の酸であるギ酸、酢酸、ジクロル酢酸、トリクロル酢
酸、酒石酸、リンゴ酸では、すぐれたスティン除去効果
が得られないことが確翳忍されている。0 Results The stain adhesion rate on the back side of the teeth was that of the present invention product 18.4 Comparative example 23. (n=5). That is, it can be seen that the product of the present invention exhibits an excellent stain removal effect even without an abrasive. It has been confirmed from other experiments that formic acid, acetic acid, dichloroacetic acid, trichloroacetic acid, tartaric acid, and malic acid, which are acids other than ascorbic acid, do not have an excellent stain removal effect.
実施例3
実施例1で用いたのと同じカプセルを配合した各種歯磨
組成物(組成物■〜X)を製造し、安定性を調べた結果
、これらは、いずれも長期間安定であった。組成物■〜
Xの組成を次に示す。Example 3 Various dentifrice compositions (compositions 1 to 1) containing the same capsules as those used in Example 1 were manufactured and their stability was examined. As a result, all of these compositions were stable for a long period of time. Composition ■~
The composition of X is shown below.
尚、組成物中、
CMC:hルボキシメチルセルロース
SDS ニラウリル硫酸Na
PEG:ポリプロピレングリコール
MFP :モノフルオロリン酸ナトリウムIMP:不溶
性メクリン酸ナトリウム
を示す。In the composition, CMC: hruboxymethylcellulose SDS Na nilauryl sulfate PEG: Polypropylene glycol MFP: Sodium monofluorophosphate IMP: Insoluble sodium meclate.
0組成物I
第2リン酸Ca 5 QCM
CO,5
カラギーナン 0.5ソルビツト
15グリセリン
15
プロピレングリコール 2
S D S 1. Qラウ
リン酸ジェタノールアミド 0.3ミリスチン酸
〃0.3
酢酸トコフェロール 0.05メチルパラ
ベン 0.05安息香酸Na
’ Q、3サツカリンNa
0.1カプセル
2.0香 料
1.0水
残O組成物■
第2リン酸Ca 5 Q無水ケ
イ酸 3
CM C1,Q
ソルビット 15グリセリン
10
プロピレングリコール 2
S D S 1. Qラウ
ロイルサルコシンNa O82ラウリン酸ジ
ェタノールアミド 1.0メチルパラベン
0.05安息香酸Na
O,1サツカリンNa O,
1カプセル 2.3香
車重
1. O水
残0組
成物■
水酸化アルミ 40
カラギーナン 1.0アルギン酸N
a Q、5グリセリン
25
プロピレングリコール 3
S D S O,3ラウロ
イルザルコシンNa 0.3ミリスチン酸ジ
エタノールアミド 0.5ブチルパラベン
0.05安息香酸Na
Q、3ザツカリンNa Q、1
塩酸クロルヘキシジン 0.O1■9
カプセル 0.2香 料
1,0水
残0組成
物■
水酸化アルミ 40
炭酸カルシウム 2
カラギーナン 1,0ソルビツト
30S D S
1.、0ラウリン酸ジエタノールアミド
1.5ミリスチン酸 〃0.5
ニコチン酸トコフェロール o、 iブチルパラ
ベン 0.05安息香酸Na
Q、5ステビオサイド
0.1カプセル 0,2香
料 1.
0水
残0組成物V
炭酸カルシウム 45
CM C1,、5
ソルビツト 20グリセリン
5
プロピレングリコール 2
S D S 2. Qラウ
リン酸ジェタノールアミド o、3ミリスチン酸
〃043
パルミチン酸 〃o、3
ブチルパラベン 0.1安息香酸Na
]、0ステビオサイド
o、 i酢酸トコフェロール
o、 1カプセル 2. Q
香 料 1
.。0 Composition I Ca diphosphate QCM
CO,5 carrageenan 0.5 sorbitol
15 Glycerin
15 Propylene glycol 2 S D S 1. Q Lauric acid jetanolamide 0.3 myristic acid
〃0.3 Tocopherol acetate 0.05 Methylparaben 0.05 Sodium benzoate
'Q, 3 Satsukarin Na
0.1 capsule
2.0 fragrance
1.0 water
Residual O composition ■ Ca diphosphate 5 Q silicic anhydride 3 CM C1,Q sorbitol 15 glycerin
10 Propylene Glycol 2 S D S 1. Q Lauroyl Sarcosine Na O82 Lauric Acid Jetanolamide 1.0 Methylparaben
0.05 Sodium benzoate
O,1 Saccharin Na O,
1 capsule 2.3 scents
Vehicle weight
1. O water
0 composition remaining ■ Aluminum hydroxide 40 Carrageenan 1.0 Alginate N
a Q, 5 glycerin
25 Propylene glycol 3 S D SO, 3 lauroylsarcosine Na 0.3 Myristic acid diethanolamide 0.5 Butylparaben
0.05 Sodium benzoate
Q, 3 Zatukarin Na Q, 1
Chlorhexidine hydrochloride 0. O1■9 Capsule 0.2 Fragrance
1,0 water
0 composition remaining ■ Aluminum hydroxide 40 Calcium carbonate 2 Carrageenan 1,0 Sorbit
30S D S
1. , 0 Lauric acid diethanolamide 1.5 Myristic acid 0.5 Tocopherol nicotinate o, i Butylparaben 0.05 Sodium benzoate
Q.5 Stevioside
0.1 capsule 0.2 fragrance 1.
0 water
0 remaining Composition V Calcium carbonate 45 CM C1,, 5 Sorbit 20 Glycerin
5 Propylene glycol 2 S D S 2. Q Lauric acid jetanolamide o, 3 myristic acid
〃043 Palmitic acid 〃o, 3 Butylparaben 0.1 Sodium benzoate
], 0 Stevioside
o, i tocopherol acetate
o, 1 capsule 2. Q
Fragrance 1
.. .
水
残0組成物■
炭酸カルシウム 45
無水ケイ酸 3
カラギーナン 1.07 )be
ッ ト
30プロピレングリコール 2
S D S 3. 。water
0 composition remaining ■ Calcium carbonate 45 Silicic anhydride 3 Carrageenan 1.07 )be
T
30 Propylene Glycol 2 S D S 3. .
ヤシ油脂肪酸 0.3パルミチン酸
ジエタノールアミド 0.3ブチルパラベン
0.02安息香酸Na
O,Qアスパルテーム o、 1酢
酸トコフエロール o、 1カプセル
2. Q香 料
1. Q水
残0組成物■
無水ケイ酸 30
CM C1,0
ソルビツト 1゜グリセリン
25
P E G 5S D S
O,3ラウロイルサルコシン
Na o、5ラウリン酸ジエタノールアミド
o、5ミリスチン酸ジェタノールアミド 0.5シ
ヨ糖ラウリン酸モノエステル 10エチルパラベン
0.02安息香酸Na
0.3ザツカリンNa
0.1ニコチン酸トコフエロール 0.05
塩酸クロルヘキシジン 0.001カプセル
2.0香 料
1.0水
残O組成物■
ピロリン酸カルシウム 50キザンタンガム
1.0ソルビツト
30プロピレングリコール 2
S D S 1.5ラウリ
ン酸ジエタノールアミド 0.3ミリスチン酸
〃0.5
PUB硬化ヒマシ油 1.0メチルパラ
ベン 02安息香酸Na
0・5ザツカリンNa
0.1酢酸トコフエロール 0.I
M F P O,76カプ
セル 2.0香 料
1.0水
残O組成物■
MP50
CM C1,0
ソルビツト 20グリセリン
5
プロピレングリコール 3
S D S 1.5パル
ミチン酸ジエタノールアミド 3.0ラクチトールモノ
ラウレート 0.5エチルパラベン
0.1安息香酸Na 1.
QサッカリンNa 0・1酢酸
トコフエロール 1.0MFP
O,76カプセル
2.0香 料
1.0水
残0組成物X
カルボポール 2.585%グリセ
リン 20.0炭酸Na
i、QS D S
1.、5メチルパラベン 0.
1安息香酸Na 0.3サツカ
リンNa 0.1カプセル
2.0香 料
1.0水
残実施例4
実施例1で用いたのと同じカプセルを配合した洗口剤と
歯肉マツサージクリームを製造し、安定性を調べた結果
、これらはいずれも長期間安定であった。これらの組成
を次に示す。Coconut oil fatty acid 0.3 palmitic acid diethanolamide 0.3 butyl paraben
0.02 Sodium benzoate
O, Q aspartame o, 1 tocopherol acetate o, 1 capsule
2. Q fragrance
1. Q water
0 composition remaining ■ Silicic anhydride 30 CM C1,0 Sorbitto 1° Glycerin
25 P E G 5S D S
O, 3 lauroyl sarcosine Na o, 5 lauric acid diethanolamide o, 5 myristic acid jetanolamide 0.5 Sucrose lauric acid monoester 10 Ethyl paraben
0.02 Sodium benzoate
0.3 Zatukarin Sodium
0.1 Tocopherol nicotinate 0.05
Chlorhexidine hydrochloride 0.001 capsule 2.0 fragrance
1.0 water
Residual O composition ■ Calcium pyrophosphate 50 Xanthan gum 1.0 Sorbit
30 Propylene glycol 2 S D S 1.5 Lauric acid diethanolamide 0.3 Myristic acid
〃0.5 PUB hydrogenated castor oil 1.0 Methylparaben 02 Sodium benzoate
0.5 Zatukarin Na
0.1 tocopherol acetate 0. I
M F P O, 76 capsules 2.0 fragrance
1.0 water
Residual O composition ■ MP50 CM C1,0 Sorbitsu 20 Glycerin
5 Propylene glycol 3 S D S 1.5 Palmitic acid diethanolamide 3.0 Lactitol monolaurate 0.5 Ethylparaben
0.1 Sodium benzoate 1.
Q Saccharin Na 0.1 Tocopherol Acetate 1.0MFP
O, 76 capsules 2.0 fragrance
1.0 water
0 remaining Composition X Carbopol 2.585% Glycerin 20.0 Sodium carbonate
i, QS D S
1. , 5 methylparaben 0.
1 Sodium benzoate 0.3 Sodium saccharin 0.1 capsule
2.0 fragrance
1.0 water
Remaining Example 4 A mouth rinse and a gingival pine surge cream containing the same capsules as those used in Example 1 were manufactured, and their stability was investigated. As a result, they were both stable for a long period of time. Their compositions are shown below.
0洗口剤
カプセル 2.0%クエン酸
0.3リン酸水素ニナトリウム
0.7ポリオキシエチレン硬化ヒマシ油5.
0香 料
1.085%グリセリン 10.0安息香
酸ナトリウム 0.5サツカリンナトリウ
ム 0.2水
残0歯肉マッザージクリーム0 mouthwash capsule 2.0% citric acid
0.3 Disodium hydrogen phosphate 0.7 Polyoxyethylene hydrogenated castor oil 5.
0 fragrance
1.085% Glycerin 10.0 Sodium Benzoate 0.5 Saccharin Sodium 0.2 Water
0 gum massage cream
Claims (4)
水溶性薬剤を芯剤とし、これを親油性物質で被覆し、さ
らにこれらを親水性物質で被覆した構造の2重カプセル
。(1) A double capsule with a structure in which a core material is a water-soluble drug selected from the group of vitamins, herbal medicines, and their extracts, which is coated with a lipophilic substance, and which is further coated with a hydrophilic substance.
水溶性薬剤を芯剤とし、これを親油性物質で被覆し、さ
らにこれらを親水性物質で被覆した構造の2重カプセル
を含有することを特徴とする口腔用組成物。(2) Contains a double capsule with a structure in which the core is a water-soluble drug selected from the group of vitamins, herbal medicines, and their extracts, which is coated with a lipophilic substance, and which is further coated with a hydrophilic substance. An oral composition characterized by:
第(2)項記載の口腔用組成物。(3) The oral composition according to claim (2), wherein the vitamin is ascorbic acid.
がゼラチンである特許請求の範囲第(3)項記載の口腔
用組成物。(4) The oral composition according to claim (3), wherein the lipophilic substance is a wax-like substance and the hydrophilic substance is gelatin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6569685A JPS61225115A (en) | 1985-03-29 | 1985-03-29 | Double capsule and oral composition containing said capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6569685A JPS61225115A (en) | 1985-03-29 | 1985-03-29 | Double capsule and oral composition containing said capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS61225115A true JPS61225115A (en) | 1986-10-06 |
Family
ID=13294430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6569685A Pending JPS61225115A (en) | 1985-03-29 | 1985-03-29 | Double capsule and oral composition containing said capsule |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61225115A (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0711544A2 (en) | 1994-10-18 | 1996-05-15 | Kao Corporation | Dentifrice composition |
JPH09175967A (en) * | 1995-12-26 | 1997-07-08 | Lion Corp | Composition for oral cavity |
WO1999012516A1 (en) * | 1997-09-10 | 1999-03-18 | Morishita Jintan Co., Ltd. | Multilayered soft capsule for eliminating foul breath and process for producing the same |
JP2004506670A (en) * | 2000-08-21 | 2004-03-04 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Aqueous toothpaste containing active ingredients and mixed and ground carrier |
JP2007522102A (en) * | 2003-12-08 | 2007-08-09 | キャドベリー シュウェップス パブリック リミテッド カンパニー | Confectionery composition to whiten solid, oral teeth |
WO2008010403A1 (en) | 2006-07-21 | 2008-01-24 | Kao Corporation | Method for preventing coloration of catechins and dentifrice composition |
WO2010143589A1 (en) * | 2009-06-08 | 2010-12-16 | ライオン株式会社 | Composition for oral cavity |
JP2012500200A (en) * | 2008-08-11 | 2012-01-05 | コルゲート・パーモリブ・カンパニー | Oral care composition comprising beads |
JP2014240411A (en) * | 2014-08-15 | 2014-12-25 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | Shelf stable capsules |
US9944886B2 (en) | 2014-12-16 | 2018-04-17 | Noxell Corporation | Coated microcapsules |
US9944887B2 (en) | 2014-12-16 | 2018-04-17 | Noxell Corporation | Coated microcapsules |
US9951294B2 (en) | 2014-12-16 | 2018-04-24 | Noxell Corporation | Coated microcapsules |
US9951293B2 (en) | 2014-12-16 | 2018-04-24 | Noxell Corporation | Coated microcapsules |
US9962321B2 (en) | 2014-12-16 | 2018-05-08 | Noxell Corporation | Compositions providing delayed release of actives |
JP2018095566A (en) * | 2016-12-08 | 2018-06-21 | アサヒグループ食品株式会社 | Water-soluble functional raw material-containing composition, soft capsule, and degradation inhibiting method of water-soluble functional raw material in soft capsule |
JP2018115144A (en) * | 2017-01-17 | 2018-07-26 | 森下仁丹株式会社 | Water-containing capsule and method for producing water-containing capsule |
US11839681B2 (en) * | 2018-07-13 | 2023-12-12 | Biogenics, Inc. | Charcoal-containing double capsule and method for manufacturing same |
-
1985
- 1985-03-29 JP JP6569685A patent/JPS61225115A/en active Pending
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0711544A2 (en) | 1994-10-18 | 1996-05-15 | Kao Corporation | Dentifrice composition |
JPH09175967A (en) * | 1995-12-26 | 1997-07-08 | Lion Corp | Composition for oral cavity |
WO1999012516A1 (en) * | 1997-09-10 | 1999-03-18 | Morishita Jintan Co., Ltd. | Multilayered soft capsule for eliminating foul breath and process for producing the same |
US6426089B1 (en) | 1997-09-10 | 2002-07-30 | Morishita Jintan Co., Ltd. | Multilayered soft capsule for eliminating bad breath and process for producing the same |
JP2004506670A (en) * | 2000-08-21 | 2004-03-04 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Aqueous toothpaste containing active ingredients and mixed and ground carrier |
JP2007522102A (en) * | 2003-12-08 | 2007-08-09 | キャドベリー シュウェップス パブリック リミテッド カンパニー | Confectionery composition to whiten solid, oral teeth |
JP4827741B2 (en) * | 2003-12-08 | 2011-11-30 | キャドベリー ホールディングス リミテッド | Confectionery composition to whiten solid, oral teeth |
WO2008010403A1 (en) | 2006-07-21 | 2008-01-24 | Kao Corporation | Method for preventing coloration of catechins and dentifrice composition |
US10213376B2 (en) | 2006-07-21 | 2019-02-26 | Kao Corporation | Method of suppressing coloration of catechins and a dentifrice composition |
US10092779B2 (en) | 2008-08-11 | 2018-10-09 | Colgate-Palmolive Company | Oral care composition comprising capsules |
JP2012500200A (en) * | 2008-08-11 | 2012-01-05 | コルゲート・パーモリブ・カンパニー | Oral care composition comprising beads |
WO2010143589A1 (en) * | 2009-06-08 | 2010-12-16 | ライオン株式会社 | Composition for oral cavity |
JP2014240411A (en) * | 2014-08-15 | 2014-12-25 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | Shelf stable capsules |
US9951294B2 (en) | 2014-12-16 | 2018-04-24 | Noxell Corporation | Coated microcapsules |
US9951293B2 (en) | 2014-12-16 | 2018-04-24 | Noxell Corporation | Coated microcapsules |
US9962321B2 (en) | 2014-12-16 | 2018-05-08 | Noxell Corporation | Compositions providing delayed release of actives |
US9944887B2 (en) | 2014-12-16 | 2018-04-17 | Noxell Corporation | Coated microcapsules |
US9944886B2 (en) | 2014-12-16 | 2018-04-17 | Noxell Corporation | Coated microcapsules |
JP2018095566A (en) * | 2016-12-08 | 2018-06-21 | アサヒグループ食品株式会社 | Water-soluble functional raw material-containing composition, soft capsule, and degradation inhibiting method of water-soluble functional raw material in soft capsule |
JP2018115144A (en) * | 2017-01-17 | 2018-07-26 | 森下仁丹株式会社 | Water-containing capsule and method for producing water-containing capsule |
WO2018135551A1 (en) * | 2017-01-17 | 2018-07-26 | 森下仁丹株式会社 | Water-containing capsule and method for producing water-containing capsule |
CN108633256A (en) * | 2017-01-17 | 2018-10-09 | 森下仁丹株式会社 | Manufacturing method containing capsule with diuresis promoting function and containing capsule with diuresis promoting function |
US11839681B2 (en) * | 2018-07-13 | 2023-12-12 | Biogenics, Inc. | Charcoal-containing double capsule and method for manufacturing same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS61225115A (en) | Double capsule and oral composition containing said capsule | |
US5424060A (en) | Dentifrice composition containing stabilized sodium percarbonate | |
AU2008296755B2 (en) | Controlled surface gelling of mucoadhesive polymers on oral mucosa | |
US5976507A (en) | Dentrifice composition containing encapsulated reactive ingredients | |
AU730963B2 (en) | Anticalculus dentifrice containing highly soluble pyrophosphate | |
US6153219A (en) | Oral composition | |
WO2002045575A2 (en) | Multicomponent biodegradable bioadhesive controlled release system for oral care products | |
JP2009536935A (en) | Tooth whitening composition | |
US5000941A (en) | Dentifrice containing microencapsulated oxygen | |
US20080274067A1 (en) | Tooth Whitening Composition | |
WO1997016159A1 (en) | Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils | |
JP3331092B2 (en) | Toothpaste composition | |
EP1693049A1 (en) | Capsule-containing oral composition | |
EP2790791B1 (en) | Liquid activation system | |
JP2003212741A (en) | Dentifrice composition | |
MX2011004574A (en) | Shelf stable capsules. | |
JPH09241139A (en) | Oral composition | |
JP3753226B2 (en) | Oral composition | |
JPH1067625A (en) | Composition for oral cavity | |
JPH08169812A (en) | Oral composition | |
WO2001001938A1 (en) | Oral composition comprising capsules | |
JPH08325127A (en) | Composition for oral cavity | |
JP2005075825A (en) | Tooth-whitening oral composition | |
MXPA00011988A (en) | Dentifrice composition containing encapsulated reactive ingredients | |
HK1144402B (en) | Controlled surface gelling of mucoadhesive polymers on oral mucosa |